Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15555
Abstract: Background/Aim: This study explored how highly selected oligometastatic gastrointestinal stromal tumour (GIST) patients subjectively experienced the discontinuation of imatinib (IM) treatment. Patients and Methods: Being an exploratory qualitative study, we applied a phenomenological and hermeneutical… read more here.
Keywords: lifeline imatinib; imatinib discontinuation; hope lifeline; oligometastatic gastrointestinal ... See more keywords